250 related articles for article (PubMed ID: 16825992)
1. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
Field JJ; Mason PJ; An P; Kasai Y; McLellan M; Jaeger S; Barnes YJ; King AA; Bessler M; Wilson DB
J Pediatr Hematol Oncol; 2006 Jul; 28(7):450-3. PubMed ID: 16825992
[TBL] [Abstract][Full Text] [Related]
2. TERC mutations in children with refractory cytopenia.
Ortmann CA; Niemeyer CM; Wawer A; Ebell W; Baumann I; Kratz CP
Haematologica; 2006 May; 91(5):707-8. PubMed ID: 16670076
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
4. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
de la Fuente J; Dokal I
Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
[TBL] [Abstract][Full Text] [Related]
5. Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Ohyashiki K; Shay JW; Ohyashiki JH
Haematologica; 2005 May; 90(5):691. PubMed ID: 15921388
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
Yamaguchi H; Baerlocher GM; Lansdorp PM; Chanock SJ; Nunez O; Sloand E; Young NS
Blood; 2003 Aug; 102(3):916-8. PubMed ID: 12676774
[TBL] [Abstract][Full Text] [Related]
7. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
[TBL] [Abstract][Full Text] [Related]
8. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.
Liang J; Yagasaki H; Kamachi Y; Hama A; Matsumoto K; Kato K; Kudo K; Kojima S
Haematologica; 2006 May; 91(5):656-8. PubMed ID: 16627250
[TBL] [Abstract][Full Text] [Related]
9. Telomerase gene mutation screening in Chinese patients with aplastic anemia.
Han B; Liu B; Cui W; Wang X; Lin J; Zhao Y
Leuk Res; 2010 Feb; 34(2):258-60. PubMed ID: 19942288
[TBL] [Abstract][Full Text] [Related]
10. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
[TBL] [Abstract][Full Text] [Related]
11. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
12. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS
Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency.
Marrone A; Stevens D; Vulliamy T; Dokal I; Mason PJ
Blood; 2004 Dec; 104(13):3936-42. PubMed ID: 15319288
[TBL] [Abstract][Full Text] [Related]
14. Dyskeratosis congenita: a genetic disorder of many faces.
Kirwan M; Dokal I
Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
[TBL] [Abstract][Full Text] [Related]
16. Dyskeratosis congenita and telomerase.
Bessler M; Wilson DB; Mason PJ
Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
[TBL] [Abstract][Full Text] [Related]
17. Dyskeratosis congenita.
Vulliamy T; Dokal I
Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
[TBL] [Abstract][Full Text] [Related]
18. Dyskeratosis congenita: telomerase, telomeres and anticipation.
Marrone A; Walne A; Dokal I
Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
[TBL] [Abstract][Full Text] [Related]
19. HuR regulates telomerase activity through TERC methylation.
Tang H; Wang H; Cheng X; Fan X; Yang F; Zhang M; Chen Y; Tian Y; Liu C; Shao D; Jiang B; Dou Y; Cong Y; Xing J; Zhang X; Yi X; Songyang Z; Ma W; Zhao Y; Wang X; Ma J; Gorospe M; Ju Z; Wang W
Nat Commun; 2018 Jun; 9(1):2213. PubMed ID: 29880812
[TBL] [Abstract][Full Text] [Related]
20. Stem cells, telomerase and dyskeratosis congenita.
Mason PJ
Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]